< 生产厂家价格 >

盐酸去氧肾上腺素(苯肾上腺素杂质A)

盐酸去氧肾上腺素(苯肾上腺素杂质A)用途

盐酸诺芬替林是一种口服活性内源性α-肾上腺素能激动剂,可用于女性压力性尿失禁的研究[1][2]。

点击显示

盐酸去氧肾上腺素(苯肾上腺素杂质A)名称

[ CAS 号 ]:
4779-94-6

[ 中文名 ]:
盐酸去甲苯福林

[ 英文名 ]:
Norphenylephrine hydrochloride

[中文别名 ]:

3-羟基-alpha-(氨基甲基)-苄醇盐酸盐

[英文别名 ]:

MFCD00012879
UNII:1FCN9TAU6R
EINECS 225-323-6
Phenylephrine Impurity 16

盐酸去氧肾上腺素(苯肾上腺素杂质A)生物活性

[ 描述 ]:

盐酸诺芬替林是一种口服活性内源性α-肾上腺素能激动剂,可用于女性压力性尿失禁的研究[1][2]。

[ 相关类别 ]:

研究领域 >> 内分泌

信号通路 >> G 蛋白偶联受体/G 蛋白 >> 肾上腺素能受体

[参考文献]

[1].

[2].

盐酸去氧肾上腺素(苯肾上腺素杂质A)物理化学性质

[ 密度 ]:
1.249g/cm3

[ 沸点 ]:
360.7ºC at 760mmHg

[ 熔点 ]:
162-164ºC(lit.)

[ 分子式 ]:
C₈H₁₂ClNO₂

[ 分子量 ]:
189.64

[ 闪点 ]:
172ºC

[ 精确质量 ]:
189.055649

[ PSA ]:
66.48000

[ LogP ]:
1.88660

[ 储存条件 ]:
库房通风低温干燥

盐酸去氧肾上腺素(苯肾上腺素杂质A)MSDS

盐酸去氧肾上腺素(苯肾上腺素杂质A)毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: DN7400000

CHEMICAL NAME :: Benzyl alcohol, alpha-aminomethyl-3-hydroxy-, hydrochloride

CAS REGISTRY NUMBER :: 4779-94-6

LAST UPDATED :: 199712

DATA ITEMS CITED :: 8

MOLECULAR FORMULA :: C8-H11-N-O2.Cl-H

MOLECULAR WEIGHT :: 189.66

WISWESSER LINE NOTATION :: QR CYQM1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 390 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 4,561,1970

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 32 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 4,561,1970

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 28 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 4,561,1970

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 17400 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- Volume(issue)/page/year: 23,1587,1981

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 3300 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 4,561,1970

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 370 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 106,440,1952

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 700 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- Volume(issue)/page/year: 23,1587,1981

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 113 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 106,440,1952

点击显示

盐酸去氧肾上腺素(苯肾上腺素杂质A)安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H302

[ 警示性声明 ]:
P301 + P312 + P330

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ 危害码 (欧洲) ]:
Xn: Harmful;

[ 风险声明 (欧洲) ]:
R22

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ RTECS号 ]:
DN7400000

盐酸去氧肾上腺素(苯肾上腺素杂质A)合成路线

盐酸去氧肾上腺素(苯肾上腺素杂质A)上下游产品

盐酸去氧肾上腺素(苯肾上腺素杂质A)上游产品

盐酸去氧肾上腺素(苯肾上腺素杂质A)下游产品

盐酸去氧肾上腺素(苯肾上腺素杂质A)文献

Selective synthesis of racemic 1-11C-labelled norepinephrine, octopamine, norphenylephrine and phenylethanolamine using [11C]nitromethane.

Appl. Radiat. Isot. 45(4) , 515-21, (1994)

A new and simple method for the selective condensation of no-carrier-added [11C]nitromethane (1) with various substituted (protected) benzaldehydes to [beta-11C]beta-nitrophenethyl alcohols was develo...

Chiral separations on multichannel microfluidic chips.

Electrophoresis 26(24) , 4774-9, (2005)

Chiral separations of FITC-labeled basic drugs on multichannel microfluidic chips with LIF detector were investigated. A preliminary screening procedure for seven neutral CDs was performed under optim...

In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.

J. Pharmacol. Exp. Ther. 301(1) , 229-33, (2002)

The role of alpha(1)-adrenoceptors in lipid mobilization and blood flow was investigated in situ using microdialysis of subcutaneous adipose tissue in severely obese subjects. The lipolysis rate was a...

更多文献